Dr. Bansal joined the faculty at Mount Sinai in 2001 after
completing Gastroenterology Fellowship at the University of Pennsylvania. In
2002 she became the Transplant Hepatology Fellowship Director, leading one of
the largest transplant hepatology fellowships in the United States. While
remaining clinically active, she has also developed an NIH-funded basic
research program focusing on understanding underlying molecular mechanisms of
liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic
therapies. Her current research interests focus on how HIV may promote
hepatic inflammation and fibrosis as well as novel treatments for Non-Alcoholic
Steatohepatitis (NASH). She became the Director of Translational Research in
the Division of Liver Diseases in 2013 and is the principal investigator in a
number of clinical trials for the treatment of Hepatitis C and NASH. Since 2015
she has also served as the Chief Medical Officer of Mount Sinai Care LLC and
Deputy Chief Medical Officer for Mount Sinai Health Partners, the population
health platform the entire Mount Sinai Health System. In this latter role, Dr. Bansal has the
opportunity to translate findings from research/clinical trials to address
population health needs in an ever-changing healthcare landscape.
Language
English
Position
PROFESSOR | Medicine, Liver Diseases
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Queens
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai Morningside and Mount Sinai West
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Pharmacology and Therapeutics Discovery [PTD]
About Me
Dr. Bansal joined the faculty at Mount Sinai in 2001 after
completing Gastroenterology Fellowship at the University of Pennsylvania. In
2002 she became the Transplant Hepatology Fellowship Director, leading one of
the largest transplant hepatology fellowships in the United States. While
remaining clinically active, she has also developed an NIH-funded basic
research program focusing on understanding underlying molecular mechanisms of
liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic
therapies. Her current research interests focus on how HIV may promote
hepatic inflammation and fibrosis as well as novel treatments for Non-Alcoholic
Steatohepatitis (NASH). She became the Director of Translational Research in
the Division of Liver Diseases in 2013 and is the principal investigator in a
number of clinical trials for the treatment of Hepatitis C and NASH. Since 2015
she has also served as the Chief Medical Officer of Mount Sinai Care LLC and
Deputy Chief Medical Officer for Mount Sinai Health Partners, the population
health platform the entire Mount Sinai Health System. In this latter role, Dr. Bansal has the
opportunity to translate findings from research/clinical trials to address
population health needs in an ever-changing healthcare landscape.
Language
English
Position
PROFESSOR | Medicine, Liver Diseases
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Queens
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai Morningside and Mount Sinai West
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Pharmacology and Therapeutics Discovery [PTD]
About Me
Dr. Bansal joined the faculty at Mount Sinai in 2001 after
completing Gastroenterology Fellowship at the University of Pennsylvania. In
2002 she became the Transplant Hepatology Fellowship Director, leading one of
the largest transplant hepatology fellowships in the United States. While
remaining clinically active, she has also developed an NIH-funded basic
research program focusing on understanding underlying molecular mechanisms of
liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic
therapies. Her current research interests focus on how HIV may promote
hepatic inflammation and fibrosis as well as novel treatments for Non-Alcoholic
Steatohepatitis (NASH). She became the Director of Translational Research in
the Division of Liver Diseases in 2013 and is the principal investigator in a
number of clinical trials for the treatment of Hepatitis C and NASH. Since 2015
she has also served as the Chief Medical Officer of Mount Sinai Care LLC and
Deputy Chief Medical Officer for Mount Sinai Health Partners, the population
health platform the entire Mount Sinai Health System. In this latter role, Dr. Bansal has the
opportunity to translate findings from research/clinical trials to address
population health needs in an ever-changing healthcare landscape.
Language
English
Position
PROFESSOR | Medicine, Liver Diseases
Hospital Affiliations
Mount Sinai Beth Israel
Mount Sinai Queens
The Mount Sinai Hospital
New York Eye and Ear Infirmary of Mount Sinai
Mount Sinai Morningside and Mount Sinai West
Research Topics
AIDS/HIV, Cell Biology, Chemokines, Fibrosis, Hepatitis C Virus, Knockout Mice, Molecular Biology, Regeneration, Transcription Factors, Transcriptional Activation and Repression, Viruses and Virology
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Pharmacology and Therapeutics Discovery [PTD]
The New York Hospital-Cornell University Medical College
1997
C. Richard Bowman Memorial Award
The New York Hospital-Cornell University Medical College
Miles and Shirley Fiterman Basic Research Award
American Gastroenterological Association
Research
Specific Clinical/Research Interests: Role of chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis; molecular regulation of hepatic fibrosis and regeneration
Current Students: Yedidya Saiman
Postdoctoral Fellows: Ana Tuyama; Ritu Agarwal
Research Personnel: Feng Hong
Summary of Research Studies: Brief Biosketch and Research Interests Dr. Bansal joined the faculty at Mount Sinai in 2001 after completing Gastroenterology Fellowship at the University of Pennsylvania. In 2002 she became the Hepatology Fellowship Director, leading one of the largest hepatology fellowships in the United States. While remaining clinically active, she has also developed an NIH-funded basic research program focusing on understanding underlying molecular mechanisms of liver fibrosis/cirrhosis in an effort to develop novel anti-fibrotic therapies. Her research interests focus on the role of Matrix Metalloproteinase-2 in liver fibrosis and regeneration and Role of the chemokine receptors, CXCR4 and CCR5, on stellate cell biology and fibrogenesis. The latter has great implications in understanding mechanism of HCV- and HIV/HCV-induced liver disease.
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Center for Advanced Medicine17 E 102nd Street, New York, NY, 10029
1199 SEIU
AETNA - Commercial
AETNA - Medicare
Affinity Medicaid-Medicare-Essential Exchange
AgeWell New York
Amidacare Medicaid
CIGNA Healthcare
Centivo
Elderplan
EmblemHealth - GHI-PPO
EmblemHealth - HIP
EmblemHealth - HIP-Medicaid
EmblemHealth - HIP-Medicare
Empire Blue Cross Blue Shield - Commercial/Exchange
Empire Blue Cross Blue Shield - Healthplus FKA Amerigroup Medicaid
Empire Blue Cross Blue Shield - Medicare
Fidelis Health Care
HealthFirst Medicaid
HealthFirst Medicare
Horizon NJ
Hotel Trades
Magnacare-Health Care
Medicare
Metroplus
Multiplan PHCS
NY Medicaid
Oxford - Freedom & Liberty
Partners Health Plan
Senior Whole Health
United Health Care - Commercial
United Health Care - Community Care Medicaid
United Health Care - Empire Plan
United Health Care - Oxford Care
United Health Care - Top Tier
VNSNY Choice Medicare
VillageCareMax
WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Bansal during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
Novo Nordisk
Pfizer Inc.
The Kinetix Group
Madrigal
Myovant
Theratechnologies
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
Theratechnologies
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
